Most cited papers from Hôpital Foch

Hôpital Foch

What are the most cited papers from Hôpital Foch?

The most cited paper from Hôpital Foch is "Autoantibodies against type I IFNs in patients with life-threatening COVID-19" (Paul Bastard et al., 2020), with 2,885 citations. Next come "High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure" (2,419) and "Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer" (1,521).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 326 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Autoantibodies against type I IFNs in patients with life-threatening COVID-19 Paul Bastard et al. · Science Open access752 authors	24 Sep 2020	2,885
2	High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure J. P. Frat et al. · New England Journal of Medicine Open access	17 May 2015	2,419
3	Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer Johannes Alfred Witjes, Thierry Lebrét, Éva Compérat et al. · European Urology	2 Jul 2016	1,521
4	A Consensus Molecular Classification of Muscle-invasive Bladder Cancer Aurélie Kamoun et al. · European Urology Open access	26 Sep 2019	1,413
5	Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial Christophe Le Tourneau et al. · The Lancet Oncology	3 Sep 2015	1,144
6	Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma Dean F. Bajorin et al. · New England Journal of Medicine Open access	2 Jun 2021	1,088
7	Churg-Strauss Syndrome Clinical Study and Long-Term Follow-Up of 96 Patients Loı̈c Guillevin, Pascal Cohen, M. Gayraud et al. · Medicine	1999	1,077
8	EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines Johannes Alfred Witjes, Éva Compérat, Nigel C. Cowan et al. · European Urology	12 Dec 2013	1,014
9	Anatomical classification of facial, cranio-facial and latero-facial clefts Paul L. Tessier · Journal of Maxillofacial Surgery	1976	889
10	Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival Alexandre Loupy, Carmen Lefaucheur, Déwi Vernerey et al. · New England Journal of Medicine Open access	25 Sep 2013	849
11	Signature of consciousness in the dynamics of resting-state brain activity Pablo Barttfeld, Lynn Uhrig, Jacobo Diego Sitt et al. · Proceedings of the National Academy of Sciences Open access	5 Jan 2015	767
12	Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial Gwénaëlle Gravis et al. · The Lancet Oncology	8 Jan 2013	747
13	Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer Lisa Derosa et al. · Nature Medicine Open access	Feb 2022	684
14	Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths Paul Bastard et al. · Science Immunology Open access195 authors	10 Aug 2021	643
15	Hypereosinophilic syndrome: A multicenter, retrospective analysis of clinical characteristics and response to therapy Princess U. Ogbogu, Bruce Scott Bochner, Joseph H. Butterfield et al. · Journal of Allergy and Clinical Immunology Open access	13 Nov 2009	629
16	Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour site Pierre Blanchard, Bertrand BAUJAT, V. Holostenco et al. · Radiotherapy and Oncology Review	21 Jun 2011	628
17	Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence Jean Bousquet et al. · Journal of Allergy and Clinical Immunology Open access102 authors	15 Oct 2019	615
18	Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2) Jean Reignier et al. · The Lancet 115 authors	8 Nov 2017	592
19	Geomorphic and geologic controls of geohazards induced by Nepal’s 2015 Gorkha earthquake Jeffrey S. Kargel et al. · Science Open access	16 Dec 2015	587
20	Treatment of Patients with the Hypereosinophilic Syndrome with Mepolizumab Marc E. Rothenberg, Amy D. Klion, Florence E. Roufosse et al. · New England Journal of Medicine Open access	16 Mar 2008	581
21	A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke Pierre Amarenco et al. · New England Journal of Medicine Open access	18 Nov 2019	579
22	TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors Scott T. Tagawa, Arjun Vasant Balar, Daniel Peter Petrylak et al. · Journal of Clinical Oncology Open access	30 Apr 2021	553
23	Pre-eclampsia: pathophysiology, diagnosis, and management Ayoubi · Vascular Health and Risk Management Open access	Jul 2011	551
24	Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications Pierre Nahon et al. · Gastroenterology Open access	16 Sep 2016	540
25	Ribavirin for Chronic Hepatitis E Virus Infection in Transplant Recipients Nassim Kamar et al. · New England Journal of Medicine Open access	19 Mar 2014	518
26	Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial Gwénaëlle Gravis, Jean‐Marie Boher, Florence Joly et al. · European Urology	21 Nov 2015	465
27	Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data Matthieu Mahévas et al. · BMJ Open access	14 May 2020	461
28	Intranasal drug delivery: An efficient and non-invasive route for systemic administration Stanislas Grassin‐Delyle, Amparo Buenestado, Emmanuel Naline et al. · Pharmacology & Therapeutics	23 Mar 2012	436
29	Autogenous Bone Grafts Taken from the Calvarium for Facial and Cranial Applications Paul L. Tessier · Clinics in Plastic Surgery	Oct 1982	436
30	Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients Myriam Delaunay et al. · European Respiratory Journal Open access	Aug 2017	427
31	The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections Gian Carlo Schito, Kurt G. Naber, Henry Botto et al. · International Journal of Antimicrobial Agents	9 Jun 2009	423
32	Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry Benjamin Terrier et al. · Arthritis & Rheumatism	5 May 2010	414
33	Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data Bruce C.V. Campbell et al. · The Lancet Neurology ReviewOpen access1,380 authors	6 Nov 2018	401
34	EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype Sandra Rebouissou et al. · Science Translational Medicine	9 Jul 2014	401
35	Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities Jean–Claude Trinchet, Cendrine Chaffaut, Valérie Bourcier et al. · Hepatology Open access	Dec 2010	400
36	Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis Alexandre Vallée, Yves Lecarpentier · Frontiers in Immunology Open access	13 Apr 2018	398
37	A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions A. Barbaud, Erik H. Collet, B. Milpied et al. · British Journal of Dermatology	8 Nov 2012	398
38	European Society for Medical Oncology (ESMO) position paper on supportive and palliative care Katja-Daniela Jordan, Matti Aapro, Stein Kaasa et al. · Annals of Oncology Open access	24 Nov 2017	395
39	Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities Luciano Garofano et al. · Nature Cancer Open access	11 Jan 2021	394
40	Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial Cora Nanette Sternberg et al. · The Lancet Oncology	11 Dec 2014	390
41	Diagnosis of 22 New Cases of Bartonella Endocarditis Didier Raoult, Pierre E. Fournier, Michel Drancourt et al. · Annals of Internal Medicine	15 Oct 1996	388
42	Evaluation and Management of Laryngopharyngeal Reflux Disease: State of the Art Review Jerome Rene Lechien, Lee Michael Akst, Abdul‐Latif Hamdan et al. · Otolaryngology Open access	12 Feb 2019	385
43	CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients Laurent Arnaud et al. · Blood	15 Jan 2011	385
44	The Succinate Dehydrogenase Genetic Testing in a Large Prospective Series of Patients with Paragangliomas Nelly Burnichon et al. · The Journal of Clinical Endocrinology & Metabolism	19 May 2009	380
45	Multimodal prehabilitation in colorectal cancer patients to improve functional capacity and reduce postoperative complications: the first international randomized controlled trial for multimodal prehabilitation Stefanus Johannes van Rooijen, Francesco Carli, Susanne Oksbjerg Dalton et al. · BMC Cancer Open access	22 Jan 2019	374
46	The Management of Vein of Galen Aneurysmal Malformations Pierre L. Lasjaunias, Soke Miang Chng, Marina Sachet et al. · Neurosurgery	18 Oct 2006	364
47	Progenitors from the central nervous system drive neurogenesis in cancer Philippe Mauffrey, Nicolas Tchitchek, Vilma Barroca et al. · Nature	15 May 2019	363
48	From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal S L Asa et al. · Endocrine Related Cancer Open access	6 Mar 2017	359
49	Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study Alexandre Loupy et al. · BMJ Open access	17 Sep 2019	356
50	Phase I study of oxaliplatin in patients with advanced cancer Jean Marc Extra, Marc Espié, Fabien M. Calvo et al. · Cancer Chemotherapy and Pharmacology	1990	346

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.